| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |